ArticlePolymers2019
Non-Chloride in Situ Preparation of Nano-Cuprous Oxide and Its Effect on Heat Resistance and Combustion Properties of Calcium Alginate.
Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Preparation and Properties of CMC-Based Composite Gel as a Flame-Retardant Dust Suppressant.Gels (Basel, Switzerland) · 2026Article
- Recent advances in metal-family flame retardants: a review.RSC advances · 2023Review
- Metal Nanoparticles-Polymers Hybrid Materials I.Polymers · 2022Article
- Hollow Dodecahedra Graphene Oxide- Cuprous Oxide Nanocomposites With Effective Photocatalytic and Bactericidal Activity.Frontiers in chemistry · 2021Article
- An Alginate Hybrid Sponge with High Thermal Stability: Its Flame Retardant Properties and Mechanism.Polymers · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
With Cu
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.